Caris Life Sciences, Inc. Common Stock (NASDAQ: CAI) last traded at $26.27, up 6.88% on the session. The quote above updates while this page is open; the figures below are drawn from Caris Life Sciences, Inc. Common Stock’s own filings and are restated only when a new one is published.
Caris Life Sciences, Inc. Common Stock trades on NASDAQ under the ticker CAI. Its market capitalisation is $7.42 billion.
Valuation measures for Caris Life Sciences, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $7.42B |
|---|---|
| Enterprise value | $7.24B |
| Price / sales | 7.50 |
| Price / book | 12.55 |
| Beta | 1.33 |
Trailing-twelve-month figures tagged in Caris Life Sciences, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $989.61M |
|---|---|
| Net income (TTM) | $105.14M |
| Operating margin | 15.49% |
| Return on equity | 17.77% |
| Cash | $819.90M |
Range and volume for CAI over the past 52 weeks.
| 52-week high | $42.50 |
|---|---|
| 52-week low | $14.19 |
| Volume | 6.35M |
| Average volume | 3.76M |
| Previous close | $24.58 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.